Literature DB >> 21132348

Production of fumonisins B2 and B4 in Tolypocladium species.

Jesper Mølgaard Mogensen1, Kirsten Amalie Møller, Pernille von Freiesleben, Roman Labuda, Elisabeth Varga, Michael Sulyok, Alena Kubátová, Ulf Thrane, Birgitte Andersen, Kristian Fog Nielsen.   

Abstract

Tolypocladium inflatum is known primarily for its production of the cyclosporines that are used as an immunosuppressive drug. However, we report here the production of the carcinogenic fumonisins B(2) and B(4) by this biotechnologically relevant fungal genus. These mycotoxins were detected in 11 strains tested from three species: Tolypocladium inflatum, T. cylindrosporum, and T. geodes. Production of fumonisins by Fusarium spp. and Aspergillus niger is highly medium- and temperature-dependent, so the effect of these parameters on fumonisin production by three T. inflatum strains was studied. Maximum production was achieved on media with high sugar content incubated at 25-30°C. Since these results demonstrate that fumonisin production could be widespread within the genus Tolypocladium, the potential contamination of commercial cyclosporine preparations with fumonisins needs to be investigated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21132348     DOI: 10.1007/s10295-010-0916-1

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  29 in total

1.  Fungal metabolite screening: database of 474 mycotoxins and fungal metabolites for dereplication by standardised liquid chromatography-UV-mass spectrometry methodology.

Authors:  Kristian Fog Nielsen; Jørn Smedsgaard
Journal:  J Chromatogr A       Date:  2003-06-20       Impact factor: 4.759

2.  Contamination of pine nuts by fumonisin produced by strains of Fusarium proliferatum isolated from Pinus pinea.

Authors:  S Marín; A J Ramos; C Vázquez; V Sanchis
Journal:  Lett Appl Microbiol       Date:  2007-01       Impact factor: 2.858

3.  Isolation and NMR characterization of fumonisin B2 and a new fumonisin B6 from Aspergillus niger.

Authors:  Maria Månsson; Marie Louise Klejnstrup; Richard K Phipps; Kristian F Nielsen; Jens C Frisvad; Charlotte H Gotfredsen; Thomas O Larsen
Journal:  J Agric Food Chem       Date:  2010-01-27       Impact factor: 5.279

4.  Production of Fumonisin B2 and B4 by Aspergillus niger on grapes and raisins.

Authors:  Jesper M Mogensen; Jens C Frisvad; Ulf Thrane; Kristian F Nielsen
Journal:  J Agric Food Chem       Date:  2010-01-27       Impact factor: 5.279

5.  Reproductive and sphingolipid metabolic effects of fumonisin B(1) and its alkaline hydrolysis product in LM/Bc mice: hydrolyzed fumonisin B(1) did not cause neural tube defects.

Authors:  Kenneth A Voss; Ronald T Riley; Maurice E Snook; Janee Gelineau-van Waes
Journal:  Toxicol Sci       Date:  2009-09-25       Impact factor: 4.849

6.  Analysis of fumonisin B1 and its hydrolysis product in tortillas.

Authors:  M E Stack
Journal:  J AOAC Int       Date:  1998 Jul-Aug       Impact factor: 1.913

7.  Fumonisin B2 production by Aspergillus niger.

Authors:  Jens C Frisvad; Jørn Smedsgaard; Robert A Samson; Thomas O Larsen; Ulf Thrane
Journal:  J Agric Food Chem       Date:  2007-10-12       Impact factor: 5.279

8.  Mycotoxins and human disease: a largely ignored global health issue.

Authors:  Christopher P Wild; Yun Yun Gong
Journal:  Carcinogenesis       Date:  2009-10-29       Impact factor: 4.944

9.  Fumonisin B2 production by Aspergillus niger in Thai coffee beans.

Authors:  P Noonim; W Mahakarnchanakul; K F Nielsen; J C Frisvad; R A Samson
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2009-01

10.  Effect of temperature and water activity on the production of fumonisins by Aspergillus niger and different Fusarium species.

Authors:  Jesper M Mogensen; Kristian F Nielsen; Robert A Samson; Jens C Frisvad; Ulf Thrane
Journal:  BMC Microbiol       Date:  2009-12-31       Impact factor: 3.605

View more
  6 in total

1.  Production of fumonisins by endophytic strains of Tolypocladium cylindrosporum and its relation to fungal virus infection.

Authors:  Iñigo Zabalgogeazcoa; Amador Alvarez; Noemi Herrero; Beatriz R Vazquez-de-Aldana
Journal:  Mycotoxin Res       Date:  2017-11-16       Impact factor: 3.833

Review 2.  Tolypocladamide H and the Proposed Tolypocladamide NRPS in Tolypocladium Species.

Authors:  Richard M Tehan; Rheannon R Blount; Ryan L Goold; Daphne R Mattos; Nicolas R Spatafora; Javier F Tabima; Romina Gazis; Chengshu Wang; Jane E Ishmael; Joseph W Spatafora; Kerry L McPhail
Journal:  J Nat Prod       Date:  2022-05-02       Impact factor: 4.803

3.  Identification and distribution of gene clusters required for synthesis of sphingolipid metabolism inhibitors in diverse species of the filamentous fungus Fusarium.

Authors:  Hye-Seon Kim; Jessica M Lohmar; Mark Busman; Daren W Brown; Todd A Naumann; Hege H Divon; Erik Lysøe; Silvio Uhlig; Robert H Proctor
Journal:  BMC Genomics       Date:  2020-07-23       Impact factor: 3.969

4.  Chromosome rearrangements shape the diversification of secondary metabolism in the cyclosporin producing fungus Tolypocladium inflatum.

Authors:  Rodrigo A Olarte; Jon Menke; Ying Zhang; Shawn Sullivan; Jason C Slot; Yinyin Huang; Jonathan P Badalamenti; Alisha C Quandt; Joseph W Spatafora; Kathryn E Bushley
Journal:  BMC Genomics       Date:  2019-02-07       Impact factor: 3.969

5.  Aptamer-Target-Gold Nanoparticle Conjugates for the Quantification of Fumonisin B1.

Authors:  Vicente Antonio Mirón-Mérida; Yadira González-Espinosa; Mar Collado-González; Yun Yun Gong; Yuan Guo; Francisco M Goycoolea
Journal:  Biosensors (Basel)       Date:  2021-01-08

6.  Metagenomic Analysis of Bacteria, Fungi, Bacteriophages, and Helminths in the Gut of Giant Pandas.

Authors:  Shengzhi Yang; Xin Gao; Jianghong Meng; Anyun Zhang; Yingmin Zhou; Mei Long; Bei Li; Wenwen Deng; Lei Jin; Siyue Zhao; Daifu Wu; Yongguo He; Caiwu Li; Shuliang Liu; Yan Huang; Hemin Zhang; Likou Zou
Journal:  Front Microbiol       Date:  2018-07-31       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.